Skip to main content

Advertisement

Log in

ROS-modulated therapeutic approaches in cancer treatment

  • Review – Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Reactive oxygen species (ROS) are produced in cancer cells as a result of increased metabolic rate, dysfunction of mitochondria, elevated cell signaling, expression of oncogenes and increased peroxisome activities. Certain level of ROS is required by cancer cells, above or below which lead to cytotoxicity in cancer cells. This biochemical aspect can be exploited to develop novel therapeutic agents to preferentially and selectively target cancer cells.

Methods

We searched various electronic databases including PubMed, Web of Science, and Google Scholar for peer-reviewed english-language articles. Selected articles ranging from research papers, clinical studies, and review articles on the ROS production in living systems, its role in cancer development and cancer treatment, and the role of microbiota in ROS-dependent cancer therapy were analyzed.

Results

This review highlights oxidative stress in tumors, underlying mechanisms of different relationships of ROS and cancer cells, different ROS-mediated therapeutic strategies and the emerging role of microbiota in cancer therapy.

Conclusion

Cancer cells exhibit increased ROS stress and disturbed redox homeostasis which lead to ROS adaptations. ROS-dependent anticancer therapies including ROS scavenging anticancer therapy and ROS boosting anticancer therapy have shown promising results in vitro as well as in vivo. In addition, response to cancer therapy is modulated by the human microbiota which plays a critical role in systemic body functions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Agarwala SS, Sabbagh MH (2001) Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment. Expert Opin Biol Ther 1:869–879

    Article  CAS  PubMed  Google Scholar 

  • Al-Abdullah ES, Al-Tuwaijri HM, Hassan HM, Al-Alshaikh MA, Habib EE, El-Emam AA (2015) Synthesis, antimicrobial and hypoglycemic activities of novel N-(1-adamantyl) carbothioamide derivatives. Molecules 20:8125–8143

    Article  CAS  PubMed  Google Scholar 

  • Albanes D et al (2014) Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Prev Res 7(9):886–895

    Article  CAS  Google Scholar 

  • Alexandre J, Nicco C, Chereau C, Laurent A, Weill B, Goldwasser F, Batteux F (2006) Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 98(4):236–244

    Article  CAS  PubMed  Google Scholar 

  • Al-Mayah A et al (2015) The non-targeted effects of radiation are perpetuated by exosomes. Mutat Res Fundam Mol Mech Mutagen 772:38–45

    Article  CAS  Google Scholar 

  • Altenhöfer S, Radermacher KA, Kleikers PW, Wingler K, Schmidt HH (2015) Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement. Antioxid Redox Signal 23:406–427

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Aunoble B, Sanches R, Didier E, Bignon Y (2000) Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int J Oncol 16:567–576

    CAS  PubMed  Google Scholar 

  • Babior BM (1999) NADPH oxidase: an update. Blood 93:1464–1476

    CAS  PubMed  Google Scholar 

  • Bae YS, Sung J-Y, Kim O-S, Kim YJ, Hur KC, Kazlauskas A, Rhee SG (2000) Platelet-derived growth factor-induced H2O2 production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem 275:10527–10531

    Article  CAS  PubMed  Google Scholar 

  • Bauer G (2012) Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling. Anticancer Res 32:2599–2624

    CAS  PubMed  Google Scholar 

  • Belfi CA, Chatterjee S, Gosky DM, Berger SJ, Berger NA (1999) Increased sensitivity of human colon cancer Cells to DNA cross-linking agents after GRP78 up-regulation. Biochem Biophys Res Comm 257(2):361–368

    Article  CAS  PubMed  Google Scholar 

  • Benhar M, Engelberg D, Levitzki A (2002) ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 3:420–425

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bey EA, Bentle MS, Reinicke KE, Dong Y, Yang C-R, Girard L, Minna JD, Bornmann WG, Gao J, Boothman DA (2007) An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci 104(28):11832–11837

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Biaglow JE, Miller RA (2005) The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy. Cancer Biol Ther 4:13–20

    Article  Google Scholar 

  • Bianchini F, Vainio H (2003) Wine and resveratrol: mechanisms of cancer prevention? Eur J Cancer Prev 12:417–425

    Article  CAS  PubMed  Google Scholar 

  • Bienert GP, Møller AL, Kristiansen KA, Schulz A, Møller IM, Schjoerring JK, Jahn TP (2007) Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J Biol Chem 282:1183–1192

    Article  CAS  PubMed  Google Scholar 

  • Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297:842–857

    Article  CAS  PubMed  Google Scholar 

  • Boyacioglu M et al (2014) The protective effects of vitamin C on the DNA damage, antioxidant defenses and aorta histopathology in chronic hyperhomocysteinemia induced rats. Exp Toxicol Pathol 66:407–413

    Article  CAS  PubMed  Google Scholar 

  • Boyer-Guittaut M et al (2014) The role of GABARAPL1/GEC1 in autophagic flux and mitochondrial quality control in MDA-MB-436 breast cancer cells. Autophagy 10:986–1003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brenner C, Pervaiz S, Clément M, Le Bras M (2005) Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol 20:205–219

    PubMed  Google Scholar 

  • Buytaert E, Dewaele M, Agostinis P (2007) Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta (BBA) Rev Cancer 1776:86–107

    Article  CAS  Google Scholar 

  • Cai J et al (2008) Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis. Neoplasia 10(1):41–51

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cardenas E, Ghosh R (2013) Vitamin E: a dark horse at the crossroad of cancer management. Biochem Pharmacol 86:845–852

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Carlberg I, Mannervik B (1975) Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 250:5475–5480

    CAS  PubMed  Google Scholar 

  • Chan DW, Liu VW, Tsao GS, Yao K-M, Furukawa T, Chan KK, Ngan HY (2008) Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis 29:1742–1750

    Article  CAS  PubMed  Google Scholar 

  • Chen J (2014) Reactive oxygen species and drug resistance in cancer chemotherapy. Austin J Clin Pathol 1:1017

    Google Scholar 

  • Chen Q, Olashaw N, Wu J (1995) Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway. J Biol Chem 270:28499–28502

    Article  CAS  PubMed  Google Scholar 

  • Chen J, Adikari M, Pallai R, Parekh HK, Simpkins H (2008) Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol 61:979–987

    Article  CAS  PubMed  Google Scholar 

  • Chen Z, Pittman EF, Romaguera J, Fayad L, Wang M, Neelapu SS, McLaughlin P, Kwak L, McCarty N (2013) Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphoma. PLoS One 8(8):e69126

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chiarugi P (2005) Review PTPs versus PTKs: the redox side of the coin. Free Radic Res 39:353–364

    Article  CAS  PubMed  Google Scholar 

  • Chou W-C, Jie C, Kenedy AA, Jones RJ, Trush MA, Dang CV (2004) Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci USA 101:4578–4583

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Clerkin J, Naughton R, Quiney C, Cotter T (2008) Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett 266:30–36

    Article  CAS  PubMed  Google Scholar 

  • Combs F Jr (2015) Biomarkers of selenium status. Nutrients 7:2209–2236

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Conklin KA (2000) Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37:1–18

    Article  CAS  PubMed  Google Scholar 

  • Cornelis MC et al (2014) Genome-wide association study of selenium concentrations. Hum Mol Genet 24(5):1469–1477

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Costello EK, Stagaman K, Dethlefsen L, Bohannan BJM, Relman DA (2012) The application of ecological theory toward an understanding of the human microbiome. Science 336:1255–1262. doi:10.1126/science.1224203

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Crompton M (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem J 341:233–249

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dai J, Weinberg RS, Waxman S, Jing Y (1999) Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93:268–277

    CAS  PubMed  Google Scholar 

  • D’Andrea GM (2005) Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 55:319–321

    Article  PubMed  Google Scholar 

  • Dansen TB, Wirtz KW (2001) The peroxisome in oxidative stress. IUBMB Life 51:223–230

    Article  CAS  PubMed  Google Scholar 

  • Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378

    Article  CAS  PubMed  Google Scholar 

  • D’Autréaux B, Toledano MB (2007) ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8:813–824

    Article  PubMed  CAS  Google Scholar 

  • Denmeade SR, Mhaka AM, Rosen DM, Brennen WN, Dalrymple S, Dach I, Olesen C, Gurel B, DeMarzo AM, Wilding G, Carducci MA, Dionne CA, Moller JV, Nissen P, Christensen SB, Isaacs JT (2012) Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy. Sci Transl Med 4(140):140ra86

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Derick H, Williams E, Cadenas E (2001) Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem J 353:411–416

    Article  Google Scholar 

  • Díaz-Laviada I, Rodríguez-Henche N (2014) The potential antitumor effects of capsaicin. In: Capsaicin as a Therapeutic Molecule. Springer Basel, pp 181–208

  • Dufour E, Gay F, Aguera K, Scoazec J-Y, Horand F, Lorenzi PL, Godfrin Y (2012) Pancreatic tumor sensitivity to plasma L-asparagine starvation. Pancreas 41:940–948

    Article  CAS  PubMed  Google Scholar 

  • Dzutsev A, Goldszmid RS, Viaud S, Zitvogel L, Trinchieri G (2015) The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. Eur J Immunol 45:17–31

    Article  CAS  PubMed  Google Scholar 

  • Engel RH, Evens AM (2005) Oxidative stress and apoptosis: a new treatment paradigm in cancer. Front Biosci J Virtual Libr 11:300–312

    Article  Google Scholar 

  • Ermolaeva MA et al (2013) DNA damage in germ cells induces an innate immune response that triggers systemic stress resistance. Nature 501:416–420

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ferraro D et al (2006) Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS). Oncogene 25:3689–3698

    Article  CAS  PubMed  Google Scholar 

  • Fidias P, Novello S (2010) Strategies for prolonged therapy in patients with advanced non-small-cell lung cancer. J Clin Oncol 28:5116–5123

    Article  PubMed  Google Scholar 

  • Fruehauf JP, Meyskens FL (2007) Reactive oxygen species: a breath of life or death? Clin Cancer Res 13:789–794

    Article  CAS  PubMed  Google Scholar 

  • Galluzzi L et al (2014) Systems biology of cisplatin resistance: past, present and future. Cell Death Dis 5:e1257

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ghavami S et al (2008) Brevinin-2R1 semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J Cell Mol Med 12:1005–1022

    Article  CAS  PubMed  Google Scholar 

  • Gianni D et al (2010) A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells. ACS Chem Biol 5:981–993

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Giles GI (2006) The redox regulation of thiol dependent signaling pathways in cancer. Curr Pharm Des 12:4427–4443

    Article  CAS  PubMed  Google Scholar 

  • Gills JJ, LoPiccolo J, Tsurutani J, Shoemaker RH, Best CJM, Abu-Asab MS, Borojerdi J, Warfel NA, Gardner ER, Danish M, Hollander MC, Kawabata S, Tsokos M, Figg WD, Steeg PS, Dennis PA (2007) Nelfinavir, a lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin Cancer Res 13(17):5183–5194

    Article  CAS  PubMed  Google Scholar 

  • Glasauer A, Chandel NS (2014) Targeting antioxidants for cancer therapy. Biochem Pharmacol 92:90–101

    Article  CAS  PubMed  Google Scholar 

  • Glasauer A, Sena LA, Diebold LP, Mazar AP, Chandel NS (2014) Targeting SOD1 reduces experimental non-small-cell lung cancer. J Clin Investig 124:117–128

    Article  CAS  PubMed  Google Scholar 

  • Glorieux C, Calderon PB (2017) Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach. Biol Chem. doi:10.1515/hsz-2017-0131

    PubMed  Google Scholar 

  • Glorieux C, Dejeans N, Sid B, Beck R, Calderon PB, Verrax J (2011) Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochem Pharmacol 82:1384–1390

    Article  CAS  PubMed  Google Scholar 

  • Goldszmid RS, Dzutsev A, Viaud S, Zitvogel L, Restifo NP, Trinchieri G (2015) Microbiota modulation of myeloid cells in cancer therapy. Cancer Immunol Res 3:103–109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141–1148

    Article  CAS  PubMed  Google Scholar 

  • Gui Q, Lu H, Zhang C, Xu Z, Yang Y (2015) Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model. Genet Mol Res 14:5642–5651

    Article  PubMed  Google Scholar 

  • Halliwell B (2007) Oxidative stress and cancer: have we moved forward? Biochem J 401:1–11

    Article  CAS  PubMed  Google Scholar 

  • Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88

    Article  CAS  PubMed  Google Scholar 

  • Hellstrand K (2002) Histamine in cancer immunotherapy: a preclinical background. In: Seminars in oncology. vol 29, No. 3. WB Saunders, pp 35–40

  • Hierro C, Monte MJ, Lozano E, Gonzalez-Sanchez E, Marin JJ, Macias RI (2014) Liver metabolic/oxidative stress induces hepatic and extrahepatic changes in the expression of the vitamin C transporters SVCT1 and SVCT2. Eur J Nutr 53:401–412

    Article  CAS  PubMed  Google Scholar 

  • Ho WJ et al (2015) Antioxidant micronutrients and the risk of renal cell carcinoma in the Women’s Health Initiative cohort. Cancer 121:580–588

    Article  CAS  PubMed  Google Scholar 

  • Holmgren A (1995) Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfide. Structure 3:239–243

    Article  CAS  PubMed  Google Scholar 

  • Hong MY, Turner ND, Carroll RJ, Chapkin RS, Lupton JR (2005) Differential response to DNA damage may explain different cancer susceptibility between small and large intestine. Expe Biol Med 230:464–471

    Article  CAS  Google Scholar 

  • Hsieh YJ, Wu CC, Chang CJ, Yu JS (2003) Subcellular localization of Photofrin® determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. J Cell Physiol 194:363–375

    Article  CAS  PubMed  Google Scholar 

  • Hu B et al (2016) The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury. Science 354:765–768

    Article  CAS  PubMed  Google Scholar 

  • Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W (2000) Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407:390–395

    Article  CAS  PubMed  Google Scholar 

  • Hurst R et al (2012) Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr 96:111–122

    Article  CAS  PubMed  Google Scholar 

  • Hyoudou K, Nishikawa M, Kobayashi Y, Umeyama Y, Yamashita F, Hashida M (2006) PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal. Free Radic Biol Med 41:1449–1458

    Article  CAS  PubMed  Google Scholar 

  • Hyoudou K, Nishikawa M, Kobayashi Y, Ikemura M, Yamashita F, Hashida M (2008) SOD derivatives prevent metastatic tumor growth aggravated by tumor removal. Clin Exp Metastasis 25:531–536

    Article  PubMed  Google Scholar 

  • Iida N et al (2013) Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342:967–970

    Article  CAS  PubMed  Google Scholar 

  • Ishikawa K et al (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320:661–664

    Article  CAS  PubMed  Google Scholar 

  • Ivanova D, Bakalova R, Lazarova D, Gadjeva V, Zhelev Z (2012) The impact of reactive oxygen species on anticancer therapeutic strategies. Adv Clin Exp Med Off Organ Wroclaw Med Univ 22:899–908

    Google Scholar 

  • Jablonska E, Vinceti M (2015) Selenium and human health: witnessing a Copernican revolution? J Environ Sci Health Part C 33:328–368

    Article  CAS  Google Scholar 

  • Jaramillo MC, Zhang DD (2013) The emerging role of the Nrf2–Keap1 signaling pathway in cancer. Genes Dev 27:2179–2191

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jiang Q (2014) Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med 72:76–90

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jing X, Ueki N, Cheng J, Imanishi H, Hada T (2002) Induction of apoptosis in hepatocellular carcinoma cell lines by emodin. Jpn J Cancer Res 93:874–882

    Article  CAS  PubMed  Google Scholar 

  • Jing Y et al (2006) Alteration of subcellular redox equilibrium and the consequent oxidative modification of nuclear factor κB are critical for anticancer cytotoxicity by emodin, a reactive oxygen species-producing agent. Free Radic Biol Med 40:2183–2197

    Article  CAS  PubMed  Google Scholar 

  • Jones RM et al (2013) Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J 32:3017–3028

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jones RM et al (2015) Lactobacilli modulate epithelial cytoprotection through the Nrf2 pathway. Cell Rep 12:1217–1225

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Juarez JC, Manuia M, Burnett ME, Betancourt O, Boivin B, Shaw DE, Tonks NK, Mazar AP, Donate F (2008) Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Natl Acad Sci 105(20):7147–7152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kansanen E, Kuosmanen SM, Leinonen H, Levonen A-L (2013) The Keap1–Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol 1:45–49

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim Y-S, Morgan MJ, Choksi S, Z-g Liu (2007) TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 26:675–687

    Article  CAS  PubMed  Google Scholar 

  • Kim Y, Wei J, Citronberg J, Hartman T, Fedirko V, Goodman M (2015) Relation of vitamin E and selenium exposure to prostate cancer risk by smoking status: a review and meta-analysis. Anticancer Res 35:4983–4996

    PubMed  Google Scholar 

  • Kirshner JR, He S, Balasubramanyam V, Kepros J, Yang C-Y, Zhang M, Du Z, Barsoum J, Bertin J (2008) Elesclomol induces cancer cell apoptosis through oxidative stress. Mol Can Ther 7(8):2319–2327

    Article  CAS  Google Scholar 

  • Kizaki M, Xian M, Sagawa M, Ikeda Y (2006) Induction of apoptosis via the modulation of reactive oxygen species (ROS) production in the treatment of myeloid leukemia. Curr Pharm Biotechnol 7:323–329

    Article  CAS  PubMed  Google Scholar 

  • Kong Q, Lillehei K (1998) Antioxidant inhibitors for cancer therapy. Med Hypotheses 51:405–409

    Article  CAS  PubMed  Google Scholar 

  • Kontek R, Kontek B, Grzegorczyk K (2013) Vitamin C modulates DNA damage induced by hydrogen peroxide in human colorectal adenocarcinoma cell lines (HT29) estimated by comet assay in vitro. Arch Med Sci AMS 9:1006–1012

    Article  CAS  PubMed  Google Scholar 

  • Kroemer G, Galluzzi L, Kepp O, Zitvogel L (2013) Immunogenic cell death in cancer therapy. Annu Rev Immunol 31:51–72

    Article  CAS  PubMed  Google Scholar 

  • Kubo T, Shimose S, Matsuo T, Tanaka K, Yasunaga Y, Sakai A, Ochi M (2006) Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells. J Orthop Res 24:1138–1144

    Article  CAS  PubMed  Google Scholar 

  • Lai W-L, Wong N-S (2005) ROS mediates 4HPR-induced posttranscriptional expression of the Gadd153 gene. Free Radic Biol Med 38(12):1585–1593

    Article  CAS  PubMed  Google Scholar 

  • Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, Zimmerman LJ, Liebler DC, Slebos RJ, Lorkiewicz PK, Higashi RM, Fan TW, Dang CV (2012) Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B Cells. Cell Metab 15(1):110–121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee K, Esselman WJ (2002) Inhibition of PTPs by H2O2 regulates the activation of distinct MAPK pathways. Free Radic Biol Med 33:1121–1132

    Article  CAS  PubMed  Google Scholar 

  • Lee W-K, Thévenod F (2006) A role for mitochondrial aquaporins in cellular life-and-death decisions? Am J Physiol Cell Physiol 291:C195–C202

    Article  CAS  PubMed  Google Scholar 

  • Lee Y-J et al (2012) Reactive oxygen species and PI3K/Akt signaling play key roles in the induction of Nrf2-driven heme oxygenase-1 expression in sulforaphane-treated human mesothelioma MSTO-211H cells. Food Chem Toxicol 50:116–123

    Article  CAS  PubMed  Google Scholar 

  • Li X, Yin D, Yin J, Chen Q, Wang R (2014) Dietary selenium protect against redox-mediated immune suppression induced by methylmercury exposure. Food Chem Toxicol 72:169–177

    Article  CAS  PubMed  Google Scholar 

  • Li Y et al (2015) Effects of vitamin E from supplements and diet on colonic α-and γ-tocopherol concentrations in persons at increased colon cancer risk. Nutr Cancer 67:73–81

    Article  CAS  PubMed  Google Scholar 

  • Lim SD et al (2005) Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62:200–207

    Article  CAS  PubMed  Google Scholar 

  • Liu Y, Min W (2002) Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res 90:1259–1266

    Article  CAS  PubMed  Google Scholar 

  • Liu J, Du J, Zhang Y, Sun W, Smith BJ, Oberley LW, Cullen JJ (2006) Suppression of the malignant phenotype in pancreatic cancer by overexpression of phospholipid hydroperoxide glutathione peroxidase. Hum Gene Ther 17:105–116

    Article  CAS  PubMed  Google Scholar 

  • Liu Y-Q et al (2013) Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents. Bioorg Med Chem 21:1248–1256

    Article  CAS  PubMed  Google Scholar 

  • Lo YY, Cruz TF (1995) Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 270:11727–11730

    Article  CAS  PubMed  Google Scholar 

  • Lo M, Ling V, Low C, Wang YZ, Gout PW (2010) Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer. Current Oncol 17:9–16

    CAS  Google Scholar 

  • Lum GB, Shelp BJ, DeEll JR, Bozzo GG (2016) Oxidative metabolism is associated with physiological disorders in fruits stored under multiple environmental stresses. Plant Sci 245:143–152

    Article  CAS  PubMed  Google Scholar 

  • Madesh M, Hajnóczky G (2001) VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J Cell Biol 155:1003–1016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Maeda H, Hori S, Ohizumi H, Segawa T, Kakehi Y, Ogawa O, Kakizuka A (2004) Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine. Cell Death Differ 11:737–746

    Article  CAS  PubMed  Google Scholar 

  • Magda D, Miller RA (2006) Motexafin gadolinium: a novel redox active drug for cancer therapy. Semin Cancer Biol 16(6):466–476

    Article  CAS  PubMed  Google Scholar 

  • Maier I, Berry DM, Schiestl RH (2014) Intestinal microbiota reduces genotoxic endpoints induced by high-energy protons. Radiat Res 181:45–53

    Article  CAS  PubMed  Google Scholar 

  • Mavragani IV, Laskaratou DA, Frey B, Candéias SM, Gaipl US, Lumniczky K, Georgakilas AG (2016) Key mechanisms involved in ionizing radiation-induced systemic effects. Curr Rev Toxicol Res 5:12–33

    Article  Google Scholar 

  • Mazdak H, Zia H (2012) Vitamin E reduces superficial bladder cancer recurrence: a randomized controlled trial. Int J Prev Med 3(2):110–115

    PubMed  PubMed Central  Google Scholar 

  • Medan D et al (2005) Regulation of Fas (CD95)-induced apoptotic and necrotic cell death by reactive oxygen species in macrophages. J Cell Physiol 203:78–84

    Article  CAS  PubMed  Google Scholar 

  • Meier B, Radeke H, Selle S, Younes M, Sies H, Resch K, Habermehl G (1989) Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-α. Biochem J 263:539–545

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Meng T-C, Fukada T, Tonks NK (2002) Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9:387–399

    Article  CAS  PubMed  Google Scholar 

  • Minamoto T, Mai M, Ze Ronai (1999) K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers—a review. Cancer Detect Prev 24:1–12

    Google Scholar 

  • Minamoto T, Ougolkov AV, Mai M (2002) Detection of oncogenes in the diagnosis of cancers with active oncogenic signaling. Expert Rev Mol Diagn 2:565–575

    Article  CAS  PubMed  Google Scholar 

  • Minegaki T et al (2014) Genetic polymorphisms in SLC23A2 as predictive biomarkers of severe acute toxicities after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. Inte J Med Sci 11:321

    Article  CAS  Google Scholar 

  • Montero AJ, Jassem J (2011) Cellular redox pathways as a therapeutic target in the treatment of cancer. Drugs 71:1385–1396

    Article  CAS  PubMed  Google Scholar 

  • Montero AJ, Diaz-Montero CM, Deutsch YE, Hurley J, Koniaris LG, Rumboldt T, Yasir S, Jorda M, Garret-Mayer E, Avisar E, Slingerland J, Silva O, Welsh C, Schuhwerk K, Seo P, Pegram MD, S. Glück S (2012) Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer. Breast Cancer Res Treat 132(1):215–223

    Article  CAS  PubMed  Google Scholar 

  • Mookerjee A et al (2006) A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo. BMC Cancer 6:267

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Mustacich D, Powis G (2000) Thioredoxin reductase. Biochem J 346:1–8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM (2006) The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic Biol Med 40:341–347

    Article  CAS  PubMed  Google Scholar 

  • Neumann CA, Fang Q (2007) Are peroxiredoxins tumor suppressors? Curr Opin Pharmacol 7:375–380

    Article  CAS  PubMed  Google Scholar 

  • Nikitaki Z et al (2016) Systemic mechanisms and effects of ionizing radiation: A new ‘old’ paradigm of how the bystanders and distant can become the players. Semin Cell Biol 37:77–95

    Google Scholar 

  • Ohba M, Shibanuma M, Kuroki T, Nose K (1994) Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol 126:1079–1088

    Article  CAS  PubMed  Google Scholar 

  • Outzen M et al (2016) Selenium status and risk of prostate cancer in a Danish population. Br J Nutr 115:1669–1677

    Article  CAS  PubMed  Google Scholar 

  • Ozben T (2007) Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 96:2181–2196

    Article  CAS  PubMed  Google Scholar 

  • Padhye S et al (2012) Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev 32:1131–1158. doi:10.1002/med.20235

    Article  CAS  PubMed  Google Scholar 

  • Papa L, Gomes E, Rockwell P (2007) Reactive oxygen species induced by proteasome inhibition in neuronal cells mediate mitochondrial dysfunction and a caspase-independent cell death. Apoptosis 12(8):1389–1405

    Article  CAS  PubMed  Google Scholar 

  • Park SB et al (2013) Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 63:419–437

    Article  PubMed  Google Scholar 

  • Pateras IS et al (2015) The DNA damage response and immune signaling alliance: is it good or bad? Nature decides when and where. Pharmacol Ther 154:36–56

    Article  CAS  PubMed  Google Scholar 

  • Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updates 7:97–110

    Article  CAS  Google Scholar 

  • Perez-Chanona E, Trinchieri G (2016) The role of microbiota in cancer therapy. Curr Opin Immunol 39:75–81

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Poillet-Perez L, Despouy G, Delage-Mourroux R, Boyer-Guittaut M (2015) Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol 4:184–192

    Article  CAS  PubMed  Google Scholar 

  • Ravid T, Heidinger JM, Gee P, Khan EM, Goldkorn T (2004) c-Cbl-mediated ubiquitinylation is required for epidermal growth factor receptor exit from the early endosomes. J Biol Chem 279:37153–37162

    Article  CAS  PubMed  Google Scholar 

  • Reid ME et al (2008) The nutritional prevention of cancer: 400 mcg per day selenium treatment. Nutr Cancer 60:155–163

    Article  CAS  PubMed  Google Scholar 

  • Reinehr R, Becker S, Eberle A, Grether-Beck S, Häussinger D (2005) Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem 280:27179–27194

    Article  CAS  PubMed  Google Scholar 

  • Ren D, Villeneuve NF, Jiang T, Wu T, Lau A, Toppin HA, Zhang DD (2011) Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc Natl Acad Sci 108:1433–1438

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Renschler MF (2004) The emerging role of reactive oxygen species in cancer therapy. Eur J Cancer 40:1934–1940

    Article  CAS  PubMed  Google Scholar 

  • Roy S, Trinchieri G (2017) Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer 17(5):271–285

    Article  CAS  PubMed  Google Scholar 

  • Roy D, Sarkar S, Felty Q (2006) Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells. Front Biosci 11:889–898

    Article  CAS  PubMed  Google Scholar 

  • Roy S, Ryals MM, Van den Bruele AB, Fitzgerald TS, Cunningham LL (2013) Sound preconditioning therapy inhibits ototoxic hearing loss in mice. J Clin Investig 123:4945–4949

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ryoo K, Huh S-H, Lee YH, Yoon KW, Cho S-G, Choi E-J (2004) Negative regulation of MEKK1-induced signaling by glutathione S-transferase Mu. J Biol Chem 279:43589–43594

    Article  CAS  PubMed  Google Scholar 

  • Sancho-Martínez SM, Prieto-García L, Prieto M, López-Novoa JM, López-Hernández FJ (2012) Subcellular targets of cisplatin cytotoxicity: an integrated view. Pharmacol Ther 136:35–55

    Article  PubMed  CAS  Google Scholar 

  • Sato K, Yuasa T, Nogawa M, Kimura S, Segawa H, Yokota A, Maekawa T (2006) A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo. Br J Cancer 95:1354–1361

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Scherz-Shouval R, Elazar Z (2007) ROS, mitochondria and the regulation of autophagy. Trends Cell Biol 17:422–427

    Article  CAS  PubMed  Google Scholar 

  • Scherz-Shouval R, Elazar Z (2011) Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 36:30–38

    Article  CAS  PubMed  Google Scholar 

  • Scherz-Shouval R, Shvets E, Elazar Z (2007a) Oxidation as a post-translational modification that regulates autophagy. Autophagy 3:371–373

    Article  CAS  PubMed  Google Scholar 

  • Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z (2007b) Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26:1749–1760

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schildknecht S et al (2014) The NOX1/4 inhibitor GKT136901 as selective and direct scavenger of peroxynitrite. Curr Med Chem 21:365–376

    Article  CAS  PubMed  Google Scholar 

  • Seifried HE, McDonald SS, Anderson DE, Greenwald P, Milner JA (2003) The antioxidant conundrum in cancer. Cancer Res 63:4295–4298

    CAS  PubMed  Google Scholar 

  • Seifried HE, Anderson DE, Fisher EI, Milner JA (2007) A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 18:567–579

    Article  CAS  PubMed  Google Scholar 

  • Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC (2004) Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal 6:289–300

    Article  CAS  PubMed  Google Scholar 

  • Shaw AT, Winslow MM, Magendantz M, Ouyang C, Dowdle J, Subramanian A, Lewis TA, Maglathin RL, Tolliday N, Jacks T (2011) Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress. Proc Natl Acad Sci 108(21):8773–8778

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shen B, He P-J, Shao C-L (2013) Norcantharidin induced DU145 cell apoptosis through ROS-mediated mitochondrial dysfunction and energy depletion. PLoS One 8:e84610

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Shinozaki K, Hosokawa Y, Hazawa M, Kashiwakura I, Okumura K, Kaku T, Nakayama E (2011) Ascorbic acid enhances radiation-induced apoptosis in an HL60 human leukemia cell line. J Radiat Res 52:229–237

    Article  CAS  PubMed  Google Scholar 

  • Siddiqui IA, Adhami VM, Saleem M, Mukhtar H (2006) Beneficial effects of tea and its polyphenols against prostate cancer. Mol Nutr Food Res 50:130–143

    Article  CAS  PubMed  Google Scholar 

  • Šimůnek T, Stérba M, Popelová O, Adamcová M, Hrdina R, Gersl V (2009) Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep 61(1):154–171

    Article  PubMed  Google Scholar 

  • Sies H, Berndt C, Jones DP (2017) Oxidative stress. Ann Rev Biochem doi:10.1146/annurev-biochem-061516-045037

    PubMed  Google Scholar 

  • Solban N, Rizvi I, Hasan T (2006) Targeted photodynamic therapy. Lasers Surg Med 38:522–531

    Article  PubMed  Google Scholar 

  • Song JJ, Lee YJ (2003) Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1. Biochem J 373:845

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Soule BP et al (2007) The chemistry and biology of nitroxide compounds. Free Radic Biol Med 42:1632–1650

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stewart BW, Wild CP (2014) World Cancer Report 2014. IARC

  • Storz P (2005) Reactive oxygen species in tumor progression. Front Biosci 10:1881–1896

    Article  CAS  PubMed  Google Scholar 

  • Sun J et al (2016) Synthesis of a novel adamantyl nitroxide derivative with potent anti-hepatoma activity in vitro and in vivo American. J Cancer Res 6:1271

    Google Scholar 

  • Sundaresan M, Yu Z-X, Ferrans VJ, Irani K, Finkel T (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270:296

    Article  CAS  PubMed  Google Scholar 

  • Suzuki-Karasaki Y, Suzuki-Karasaki M, Uchida M, Ochiai T (2014) Depolarization controls TRAIL-sensitization and tumor-selective killing of cancer cells: crosstalk with ROS. Front Oncol 4:128

    Article  PubMed  PubMed Central  Google Scholar 

  • Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Can Res 51:794–798

    CAS  Google Scholar 

  • Takemura N et al (2014) Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome. Nat Commun 5:3492. doi:10.1038/ncomms4492

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Tian X et al (2014) Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma. Eur J Pharm Biopharm 87:445–453

    Article  CAS  PubMed  Google Scholar 

  • Tiku M, Liesch J, Robertson F (1990) Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines. J Immunol 145:690–696

    CAS  PubMed  Google Scholar 

  • Tobe R, Yoo M-H, Fradejas N, Carlson BA, Calvo S, Gladyshev VN, Hatfield DL (2012) Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanism. Biochem J 445:423–430

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Toler SM, Noe D, Sharma A (2006) Selective enhancement of cellular oxidative stress by chloroquine: implications for the treatment of glioblastoma multiforme. Neurosurg Focus 21:1–4

    Article  Google Scholar 

  • Touchefeu Y et al (2014) Systematic review: the role of the gut microbiota in chemotherapy-or radiation-induced gastrointestinal mucositis—current evidence and potential clinical applications. Aliment Pharmacol Ther 40:409–421

    CAS  PubMed  Google Scholar 

  • Townsend DM, Tew KD (2003) The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22:7369

    Article  CAS  PubMed  Google Scholar 

  • Trachootham D et al (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate. Cancer Cell 10:241–252

    Article  CAS  PubMed  Google Scholar 

  • Traverso N et al (2013) Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev 2013:972913. doi:10.1155/2013/972913

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Uchikura K et al (2004) Lipopolysaccharides induced increases in Fas ligand expression by Kupffer cells via mechanisms dependent on reactive oxygen species. Am J Physiol Gastrointest Liver Physiol 287:G620–G626

    Article  CAS  PubMed  Google Scholar 

  • Ushio-Fukai M, Nakamura Y (2008) Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266:37–52

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vacchelli E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L (2013) Trial Watch: Toll-like receptor agonists for cancer therapy. Oncoimmunology 2:e25238

    Article  PubMed  PubMed Central  Google Scholar 

  • Venkataraman S et al (2005) Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 24:77–89

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Yi J (2008) Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 7:1875–1884

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Zhang J, Xu T (2007) Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo. Toxicol Appl Pharmacol 218:88–95

    Article  CAS  PubMed  Google Scholar 

  • Wang Y et al (2015) Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism. Food Chem Toxicol 83:251–260

    Article  PubMed  CAS  Google Scholar 

  • Weekley CM, Aitken JB, Finney L, Vogt S, Witting PK, Harris HH (2013) Selenium metabolism in cancer cells: the combined application of XAS and XFM techniques to the problem of selenium speciation in biological systems. Nutrients 5:1734–1756

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wright ME et al (2009) Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland. Eur J Cancer 45:1824–1830

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wu X-J, Hua X (2007) Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound. Cancer Biol Ther 6:646–647

    Article  CAS  PubMed  Google Scholar 

  • Wu JH, Miao W, Hu LG, Batist G (2010) Identification and characterization of novel Nrf2 inducers designed to target the intervening region of Keap1. Chem Biol Drug Des 75:475–480

    Article  CAS  PubMed  Google Scholar 

  • Wu X, Cheng J, Wang X (2017) Dietary antioxidants: potential anticancer agents. Nutr Cancer 69(4):521–533

    Article  CAS  PubMed  Google Scholar 

  • Yamagishi S-I et al (2004) Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling. Am J Pathol 165:1865–1874

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yi J, Gao F, Shi G, Li H, Wang Z, Shi X, Tang X (2002) The inherent cellular level of reactive oxygen species: one of the mechanisms determining apoptotic susceptibility of leukemic cells to arsenic trioxide. Apoptosis 7:209–215

    Article  CAS  PubMed  Google Scholar 

  • Yi J, Yang J, He R, Gao F, Sang H, Tang X, Richard DY (2004) Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Can Res 64:108–116

    Article  CAS  Google Scholar 

  • Yoshida T et al (2017) Apocynin and enzymatically modified isoquercitrin suppress the expression of a NADPH oxidase subunit p22phox in steatosis-related preneoplastic liver foci of rats. Exp Toxicol Pathol 69:9–16

    Article  CAS  PubMed  Google Scholar 

  • Yoshida T, Goto S, Kawakatsu M, Urata Y, Li T-S (2012) Mitochondrial dysfunction, a probable cause of persistent oxidative stress after exposure to ionizing radiation. Free Radic Res 46(2):147–153

    Article  CAS  PubMed  Google Scholar 

  • Yours S, Liochev S, Fridovich I, Koppenol W (1999) The relative importance of ho and onoo-in mediating the toxicity of o-. Author’s reply. Free Radic Biol Med 26:777–778

    Article  Google Scholar 

  • Zhang L et al (2011) New insight into the Nox4 subcellular localization in HEK293 cells: first monoclonal antibodies against Nox4. Biochimie 93:457–468

    Article  CAS  PubMed  Google Scholar 

  • Zhao X-B et al (2014) Design and synthesis of novel spin-labeled camptothecin derivatives as potent cytotoxic agents. Bioorg Med Chem 22:6453–6458

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhu X, Wang K, Zhang K, Zhu L, Zhou F (2014) Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells. Toxicol Lett 227:65–73

    Article  CAS  PubMed  Google Scholar 

  • Zhu X-H et al (2016) Synthesis, crystal structure, superoxide scavenging activity, anticancer and docking studies of novel adamantyl nitroxide derivatives. J Mol Struct 1108:611–617

    Article  CAS  Google Scholar 

  • Zhu S, Pabla N, Tang C, He L, Dong Z (2015) DNA damage response in cisplatin-induced nephrotoxicity. Arch Toxicol 89:2197–2205

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhu J, Song X, Lin H-P, Young DC, Yan S, Marquez VE, Chen C-S (2002) Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents. J Natl Cancer Inst 94:1745–1757

    Article  CAS  PubMed  Google Scholar 

  • Zitvogel L, Galluzzi L, Viaud S, Vétizou M, Daillère R, Merad M, Kroemer G (2015) Cancer and the gut microbiota: an unexpected link. Sci Transl Med 7(271):271ps1

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Muhammad Hassan Raza.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Funding

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raza, M.H., Siraj, S., Arshad, A. et al. ROS-modulated therapeutic approaches in cancer treatment. J Cancer Res Clin Oncol 143, 1789–1809 (2017). https://doi.org/10.1007/s00432-017-2464-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-017-2464-9

Keywords

Navigation